Background: Mitomycin C has been found clinically useful in the treatment of colorectal cancer when administered via the hepatic artery. In a prospective therapeutic trial, we studied the effect of superselective intraarterial chemotherapy with mitomycin C in patients with hepatic metastases from co
Superselective intra-arterial chemotherapy with mitomycin for gallbladder cancer
โ Scribed by T. Matsumata; K. Yamamoto; K. Sugimachi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 112 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
HERE ARE many reports2-8 indicating palli-T ative success in the treatment of inoperable cancers with chemotherapeutic agents administered intra-arterially. They have shown that relief of pain, regression in tumor size, and biopsy evidence of tumor necrosis in the follow-up period can be achieved in
Twenty-eight patients with locally advanced breast cancer per cent. In 33 per cent of patients the lateral thoracic received four doses of regional chemotherapy via artery did not contribute to breast perfusion and a large angiographically placed percutaneous catheters into the area of the lateral a
Twenty-one patients with inoperable colon cancer in the pelvis were treated with intra-arterial 5-fluorouracil (5-FU) and mitomycin C, given bilaterally into the internal iliac arteries. Seventeen of the 21 patients had failed previous radiation therapy and 15 had also failed systemic intravenous ch